HCA Healthcare, Inc. (NYSE:HCA) Holdings Lifted by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.9% in the third quarter, according to its most recent filing with the SEC. The firm owned 12,228 shares of the company’s stock after acquiring an additional 572 shares during the quarter. Motley Fool Asset Management LLC’s holdings in HCA Healthcare were worth $4,958,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of HCA. MFA Wealth Advisors LLC bought a new position in HCA Healthcare during the 2nd quarter valued at $27,000. Unique Wealth Strategies LLC bought a new stake in HCA Healthcare in the second quarter worth about $28,000. Bangor Savings Bank boosted its position in shares of HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC lifted its stake in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the last quarter. Finally, Capital Performance Advisors LLP bought a new position in shares of HCA Healthcare in the third quarter valued at $41,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.2 %

HCA stock opened at $326.95 on Wednesday. The business’s 50-day simple moving average is $368.82 and its 200 day simple moving average is $358.90. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a twelve month low of $250.67 and a twelve month high of $417.14. The company has a market cap of $82.82 billion, a PE ratio of 14.68, a price-to-earnings-growth ratio of 1.26 and a beta of 1.63.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,155 shares of company stock valued at $5,608,990. 1.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

HCA has been the subject of several analyst reports. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. KeyCorp cut their target price on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price target for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Finally, Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $380.29.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.